Apricus Biosciences, Inc. (Nasdaq: APRI) announced that Greece has granted Apricus’ commercialization partner, Recordati, market approval for Vitaros®, an on-demand ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE